In addition, FXR agonists such as CDCA and GW4064 induce the apoptosis of breast cancer cells and activate the FXR-small heterodimer partner (SHP)-liver receptor homolog-1 (LRH-1) network (Swales et al., 2006). Here, NR0B2 is linked to breast carcinoma.